Sanuwave (SNWV) stated that enrollment for the last part of their phase III study of ‘dermaPACE’ is set to begin before the end of Q2 – which is less than 30 days away. This is a huge catalyst for the company’s shares, which have traded completely under the radar thus far. dermaPACE is a device […]